Methotrexate (MTX) is an important chemotherapeutic ... in median MTX plasma levels between patients with and without mucositis at T24 or T48 over all courses or per course. This was confirmed ...

Chemotherapy-induced oral mucositis has an adverse effect on patient outcome and represents a dose-limiting toxicity for chemotherapeutic agents such as fluorouracil, methotrexate and purine ...

Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients.